scholarly journals Brief, Instructional Smokeless Tobacco Use Among Cigarette Smokers Who Do Not Intend to Quit: A Pilot Randomized Clinical Trial

2013 ◽  
Vol 16 (4) ◽  
pp. 397-405 ◽  
Author(s):  
J. L. Burris ◽  
M. J. Carpenter ◽  
A. E. Wahlquist ◽  
K. M. Cummings ◽  
K. M. Gray
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Tobacco Use ◽  
Smokeless Tobacco ◽  
Cigarette Smokers ◽  
Smokeless Tobacco Use

scholarly journals A randomized clinical trial of nicotine lozenge for smokeless tobacco use

2009 ◽  
Vol 11 (12) ◽  
pp. 1415-1423 ◽  
Author(s):  
Jon O. Ebbert ◽  
Herbert H. Severson ◽  
Ivana T. Croghan ◽  
Brian G. Danaher ◽  
Darrell R. Schroeder
Keyword(s):  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Tobacco Use ◽  
Smokeless Tobacco ◽  
Nicotine Lozenge ◽  
Smokeless Tobacco Use

scholarly journals Transitions to smokeless tobacco use among adult cigarette smokers in the Population Assessment of Tobacco and Health (PATH) Study, Waves 3–5 (2015–2019)

2021 ◽  
pp. tobaccocontrol-2021-056907
Author(s):  
Rebecca A Jackson ◽  
Chunfeng Ren ◽  
Blair Coleman ◽  
Hannah R Day ◽  
Cindy M Chang ◽  
...  
Keyword(s):  
Tobacco Use ◽  
Smokeless Tobacco ◽  
Health Study ◽  
Dual Use ◽  
Cigarette Smokers ◽  
Population Assessment ◽  
Current Cigarette ◽  
Smokeless Tobacco Use ◽  
Using Data

ObjectiveExamine patterns of dual use of cigarettes and smokeless tobacco and complete switching over time among adult current cigarette smokers using data from the Population Assessment of Tobacco and Health Study Wave 3 (2015–2016), Wave 4 (2016–2018) and Wave 5 (2018–2019).MethodsWe examined four tobacco use states among 6834 exclusive smokers and 372 dual users at Wave 3 with two waves of follow-up data: exclusive cigarette use, exclusive smokeless tobacco use, dual use and use of neither product.ResultsAmong exclusive smokers at Wave 3, only 1.6% (95% CI: 1.3% to 2.1%) transitioned to dual use at Wave 4, and 0.1% (95% CI: 0.07% to 0.2%) switched to exclusive smokeless tobacco use. Among exclusive smokers who switched to dual use, 53.1% (95% CI: 40.9% to 64.9%) returned to exclusive cigarette smoking, 34.3% (95% CI: 23.8% to 46.6%) maintained dual use and 12.6% (95% CI: 7.0% to 21.7%) did not smoke cigarettes after an additional wave of follow-up. Dual users at Wave 3 were likely to maintain their dual use status at Wave 4, 51.2% (95% CI: 46.1% to 56.3%) and Wave 5, 47.9% (95% CI: 40.1% to 55.8%).ConclusionsVery few cigarette smokers transition to smokeless tobacco use, and among those who do, dual use is more common than exclusive smokeless tobacco use. Further, the majority of exclusive cigarette smokers who transition to dual use at Wave 4 continue smoking cigarettes at Wave 5, either as dual users or as exclusive smokers.

Assessing quality-adjusted years of life lost associated with exclusive cigarette smoking and smokeless tobacco use

2021 ◽  
pp. 106707
Author(s):  
Xin Xu ◽  
Leah Fiacco ◽  
Brian Rostron ◽  
Ghada Homsi ◽  
Esther Salazar ◽  
...  
Keyword(s):  
Cigarette Smoking ◽  
Tobacco Use ◽  
Smokeless Tobacco ◽  
Years Of Life Lost ◽  
Smokeless Tobacco Use

scholarly journals Prevalence and Correlates of Snuff Use, and its Association With Tuberculosis, Among Women Living With HIV in South Africa

2018 ◽  
Vol 21 (8) ◽  
pp. 1087-1092 ◽  
Author(s):  
Jessica L Elf ◽  
Ebrahim Variava ◽  
Sandy Chon ◽  
Limakatso Lebina ◽  
Katlego Motlhaoleng ◽  
...  
Keyword(s):  
South Africa ◽  
Tobacco Use ◽  
Smokeless Tobacco ◽  
People Living With Hiv ◽  
Potential Health ◽  
Adjusted Analysis ◽  
Women Living With Hiv ◽  
Urine Cotinine ◽  
Smokeless Tobacco Use ◽  
Living With Hiv

Abstract Introduction A higher proportion of people living with HIV (PLWH) smoke compared to the general population, but little information exists about the prevalence and correlates of smokeless tobacco use among PLWH. In South Africa, dry powdered tobacco is inhaled nasally as snuff. Methods A cross-sectional survey among PLWH attending three HIV clinics was conducted. Snuff use was assessed via self-report and urine cotinine. Results Given the low (3%) prevalence of snuff use among men, analysis was restricted to n = 606 nonsmoking women living with HIV. Half (n = 298, 49%) were snuff users, the majority of whom (n = 244, 84%) had a positive urine cotinine test. In adjusted analysis, snuff use was negatively associated with higher education (relative risk [RR] 0.55; 95% confidence interval [CI]: 0.39, 0.77) and mobile phone ownership (RR 0.83; 95% CI: 0.71, 0.98), and positively associated with ever having tuberculosis (TB) (RR 1.22; 95% CI: 1.03, 1.45). In adjusted analysis, with current TB as the outcome, snuff use was marginally statistically significantly associated with a twofold increase in odds of a current TB diagnosis (odds ratio [OR] 1.99; 95% CI: 0.98, 4.15). Discussion A high proportion of nonsmoking South African women living with HIV use snuff, which was a risk factor for TB. Additional research is needed to understand the relationship between snuff, TB, and other potential health risks. Implications PLWH have a higher prevalence of smoking than their seronegative peers, but there is a paucity of research on smokeless tobacco use in this population, especially in low-resource settings. TB is the leading cause of death among PLWH, and with improvements to HIV treatment and care, PLWH are at greater risk of tobacco-related diseases. We report an extremely high prevalence of snuff use among women living with HIV in South Africa. Further, in this population snuff use is positively associated with ever having a TB diagnosis, as well as currently having TB.

Sign in / Sign up

Export Citation Format

Share Document